Covered recipient · General Payments record
MUHAMMAD N KHAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$1,708.98
- Reported across 61 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $210.06 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $70.73 | 3 |
| GlaxoSmithKline, LLC. | $42.05 | 3 |
| ABBVIE INC. | $29.27 | 1 |
| Pulmonx Corporation | $24.65 | 1 |
| Mylan Specialty L.P. | $24.00 | 1 |
| Shionogi Inc | $19.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.27 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104061428 | CMS |
| AstraZeneca Pharmaceuticals LP | $32.98 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105865246 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.07 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105415113 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.68 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105209994 | CMS |
| GlaxoSmithKline, LLC. | $13.31 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116001266 | CMS |
| GlaxoSmithKline, LLC. | $15.24 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116161424 | CMS |
| GlaxoSmithKline, LLC. | $13.50 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116225970 | CMS |
| Mylan Specialty L.P. | $24.00 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147295515 | CMS |
| Pulmonx Corporation | $24.65 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087848477 | CMS |
| Shionogi Inc | $19.36 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154339368 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.